Skip to main content
Retour
Watch Compare

Edesa Biotech, Inc.

Qualité des données : 83%
EDSA
NASDAQ Manufacturing Chemicals
5,14 €
▼ 0,22 € (-4,10%)
6 months return
—
Momentum
Neutral
ROE
-55,66%

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-55,66%
En dessous de la moyenne du secteur (-54,47%)
ROIC-47,00%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio16,82
Interest CoverageN/A

Valorisation

PE (TTM)
-6,46
En dessous de la moyenne du secteur (-1,50)
P/B Ratio3,62
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -7,89 M

Price History

Tendances Financières

Objectif de Cours des Analystes

3 analystes
Buy
+114.0%
upside to target
Actuel
5,14 €
Consensus Target
11,00 €
5,00 €
Bas
19,00 €
Haut
Prévisions
BPA Prévisionnel
-1,74 €
CA Est.
0,0

Surprises de Résultats

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -0,26 € · Rev Est: 0,0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -0,30 € -0,25 € -0,32 € -0,28 € — —
Estimate -0,30 € -0,26 € -0,27 € -0,45 € -0,26 € -0,55 €
Surprise -1,69% +5,06% -20,00% +37,78% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -55,66% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -7,82 M
ROE -55,66% ROA -52,96%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -7,89 M
ROIC -47,00% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 16,82
Debt / Equity N/A Current Ratio 16,82
Interest Coverage N/A Asset Turnover N/A
Working Capital 11,96 M Tangible Book Value 12,00 M

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -6,46 · EV/EBITDA: N/A
P/E Ratio -6,46 Forward P/E N/A
P/B Ratio 3,62 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -15,63%
Market Cap 50,51 M Enterprise Value 38,41 M

Per Share

EPS: N/A · FCF/Share: -0,95
EPS (Diluted TTM) N/A Revenue / Share N/A
FCF / Share -0,95 OCF / Share -0,95
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 100,98% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 100,98%
SBC-Adj. FCF -8,62 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 0,0
Net Income -7,19 M -6,17 M -8,37 M -17,55 M -13,34 M
EPS (Diluted) — — — — —
Gross Profit — — — — —
Operating Income -7,91 M -7,01 M -9,22 M -18,37 M -23,68 M
EBITDA — — — — —
R&D Expenses 3,67 M 2,88 M 4,79 M 13,34 M 17,95 M
SG&A Expenses — — — — —
D&A 119 273,0 186 049,0 183 471,0 118 188,0 118 788,0
Interest Expense — — — — —
Income Tax 800,0 800,0 800,0 800,0 800,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 13,53 M 3,81 M 8,89 M 11,58 M 14,58 M
Total Liabilities — 1,83 M 1,84 M 2,18 M 1,53 M
Shareholders' Equity 12,45 M 1,98 M 7,05 M 9,39 M 13,06 M
Total Debt — — — — —
Cash & Equivalents 10,80 M 1,00 M 5,40 M 7,09 M 7,84 M
Current Assets 11,51 M 1,68 M 6,44 M 9,09 M 12,09 M
Current Liabilities 1,08 M 1,83 M 1,82 M 2,14 M 1,46 M

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1605 pairs)
Métrique Action Médiane du Secteur
P/E -6,5 -1,5
P/B 3,6 1,6
ROE % -55,7 -54,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3